Tamtam India Pharmaceutical Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 09-12-2024
- Paid Up Capital ₹ 1.00 M
as on 09-12-2024
- Company Age 6 Year, 4 Months
- Last Filing with ROC 31 Mar 2020
- Revenue 402.86%
(FY 2020)
- Profit 278.25%
(FY 2020)
- Ebitda 318.59%
(FY 2020)
- Net Worth 4.20%
(FY 2020)
- Total Assets 156.53%
(FY 2020)
About Tamtam India Pharmaceutical
The Company is engaged in the Fmcg Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2020. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 1.00 M, as per Ministry of Corporate Affairs (MCA) records.
Shubham Kumar and Shashank Dubey serve as directors at the Company.
- CIN/LLPIN
U93090MH2018PTC312951
- Company No.
312951
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
21 Aug 2018
- Date of AGM
31 Dec 2020
- Date of Balance Sheet
31 Mar 2020
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Thane, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Tamtam India Pharmaceutical?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Shubham Kumar  | Director | 21-Aug-2018 | Current |
| Shashank Dubey | Director | 21-Aug-2018 | Current |
Financial Performance of Tamtam India Pharmaceutical.
Tamtam India Pharmaceutical Private Limited, for the financial year ended 2020, experienced significant growth in revenue, with a 402.86% increase. The company also saw a substantial improvement in profitability, with a 278.25% increase in profit. The company's net worth moved up by a moderate rise of 4.2%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Tamtam India Pharmaceutical?
In 2020, Tamtam India Pharmaceutical had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Tamtam India Biotechnology Private LimitedActive 8 months 10 daysShubham Kumar and Shashank Dubey are mutual person
- Shivkusuma Healthcare And Hospital Private LimitedActive 3 years 4 months
Shubham Kumar and Shashank Dubey are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Tamtam India Pharmaceutical?
Unlock and access historical data on people associated with Tamtam India Pharmaceutical, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Tamtam India Pharmaceutical, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Tamtam India Pharmaceutical's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
